Impact Biomedical
Impact BioMedical Inc. is dedicated to discovering, validating, and patenting innovative science and technologies in biopharmaceuticals and consumer healthcare, aiming to improve human health and wellness globally. The company leverages strategic partnerships and continuous innovation to develop new products and treatment options across various health sectors.
Industries
Nr. of Employees
small (1-50)
Impact Biomedical
1400 Broadfield Blvd., Suite 130, Houston, TX 77084
Products
Polyphenol-based therapeutic formulations
Small-molecule polyphenol compositions designed to enhance potency, bioavailability, and permeability for potential therapeutic applications in oncology, neurology, and inflammatory disease.
Antiviral polyphenol blends for supplement and Rx exploration
Naturally sourced polyphenol compositions developed for antiviral activity, positioned for over‑the‑counter supplement use and potential prescription applications pending further development.
Low-glycemic sugar composition for food and supplement use
Multi-sugar formulations paired with inositol intended to reduce glycemic response and support diet-related therapeutic claims.
Portable clean-room level air purification systems
Patented portable filtration systems designed to provide near clean-room air quality using novel filter media and U.S. manufacturing.
Polyphenol-based therapeutic formulations
Small-molecule polyphenol compositions designed to enhance potency, bioavailability, and permeability for potential therapeutic applications in oncology, neurology, and inflammatory disease.
Antiviral polyphenol blends for supplement and Rx exploration
Naturally sourced polyphenol compositions developed for antiviral activity, positioned for over‑the‑counter supplement use and potential prescription applications pending further development.
Low-glycemic sugar composition for food and supplement use
Multi-sugar formulations paired with inositol intended to reduce glycemic response and support diet-related therapeutic claims.
Portable clean-room level air purification systems
Patented portable filtration systems designed to provide near clean-room air quality using novel filter media and U.S. manufacturing.
Services
Structuring and managing development, licensing, co-development, and joint-venture relationships for technology advancement and commercialization.
Out-licensing of platform compositions and support for commercial label development and market entry.
Structuring and managing development, licensing, co-development, and joint-venture relationships for technology advancement and commercialization.
Out-licensing of platform compositions and support for commercial label development and market entry.
Expertise Areas
- Preclinical development for oncology, neurology, and inflammatory disease
- Formulation development for small molecules and botanical actives
- Antiviral and antimicrobial product development
- Nutraceutical and OTC supplement development
Key Technologies
- Polyphenol-based formulation chemistry
- Botanical terpene-derived actives
- Antiviral polyphenol blends
- Low-glycemic sugar composition technology
News & Updates
Impact BioMedical Inc. and Dr Ashley's Limited have announced a strategic merger to accelerate market reach for innovative pharmaceutical patents.
Impact BioMedical Inc. announced stock activity and pricing details, with no material development in its business affairs.
Impact BioMedical Inc. announced the acquisition of Celios®, a company specializing in advanced air purification technology.
Frank D. Heuszel, CEO, will participate in The Microcap Conference 2025, discussing the company's recent developments.
The company shared recent achievements, including a successful IPO and progress in technology development.
Impact BioMedical Inc. and Dr Ashley's Limited have announced a strategic merger to accelerate market reach for innovative pharmaceutical patents.
Impact BioMedical Inc. announced stock activity and pricing details, with no material development in its business affairs.
Impact BioMedical Inc. announced the acquisition of Celios®, a company specializing in advanced air purification technology.
Frank D. Heuszel, CEO, will participate in The Microcap Conference 2025, discussing the company's recent developments.
The company shared recent achievements, including a successful IPO and progress in technology development.